The September 2024 LIFT-AD trial termination after meeting enrollment demonstrates that this approach, despite decades of development, does not slow Alzheimer's cognitive decline in humans
Contact us Mail us at [email protected] Request a sample quote Schedule a consultation Dont just participate in the anti-aging market lead it
What caught my attention as someone who lives in regulatory approvals all day: This isn't just a new product launch it required demonstrating that each ingredient contributes to the combined effect, not just proving the mix is "safe enough." It's part of a broader US push to move more verified-safe drugs from prescription-only to OTClowering costs, cutting down unnecessary doctor visits, and increasing consumer choice
J.BronskillM
Results: GHK-Cu alleviated weight loss, improved the disease activity index (DAI), reduced colonic edema and shortening, attenuated inflammatory damage, increased goblet cell numbers, suppressed inflammatory cytokines such as TNF-, IL-6, and IL-1, and promoted mucosal repair